104 related articles for article (PubMed ID: 3761355)
21. Lymphocyte subpopulations in Crohn's disease and chronic ulcerative colitis.
Sorensen SF; Hoj L
Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):41-8. PubMed ID: 320824
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
23. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
Strugala V; Dettmar PW; Pearson JP
Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
[TBL] [Abstract][Full Text] [Related]
24. Dietary allergy evaluated by PRIST and RAST in inflammatory bowel disease.
Brignola C; Miniero R; Campieri M; Bazzocchi G; Vegetti S; Farruggia P; Lanfranchi GA
Hepatogastroenterology; 1986 Jun; 33(3):128-30. PubMed ID: 3744282
[TBL] [Abstract][Full Text] [Related]
25. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease.
Yantiss RK; Odze RD
Am J Gastroenterol; 2007 Apr; 102(4):890-904. PubMed ID: 17324129
[TBL] [Abstract][Full Text] [Related]
26. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
28. The use of proliferating cell nuclear antigen (PCNA) expression and intraepithelial lymphocyte count in the differential diagnosis of inflammatory bowel disease.
Keller K; Koch HK
Ital J Gastroenterol; 1994 Jun; 26(5):233-7. PubMed ID: 7919464
[TBL] [Abstract][Full Text] [Related]
29. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
30. [Functional status of intestinal t lymphocytes, regulatory mechanisms, and their variations in the course of Crohn disease and ulcerative colitis].
Boirivant M; Marini M; Di Felice G
Ann Ist Super Sanita; 1999; 35(2):283-9. PubMed ID: 10645662
[TBL] [Abstract][Full Text] [Related]
31. Cytokine production in inflammatory bowel disease.
Miura M; Hiwatashi N
J Clin Lab Immunol; 1985 Oct; 18(2):81-6. PubMed ID: 3908685
[TBL] [Abstract][Full Text] [Related]
32. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
33. Intraepithelial lymphocyte eotaxin-2 expression and perineural mast cell degranulation differentiate allergic/eosinophilic colitis from classic IBD.
Torrente F; Barabino A; Bellini T; Murch SH
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):300-7. PubMed ID: 24813533
[TBL] [Abstract][Full Text] [Related]
34. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
35. 'Microerosions' in rectal biopsies in Crohn's disease.
Poulsen SS; Pedersen NT; Jarnum S
Scand J Gastroenterol; 1984 Jul; 19(5):607-12. PubMed ID: 6474082
[TBL] [Abstract][Full Text] [Related]
36. E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies.
Makiyama K; Selby WS; Jewell DP
Clin Exp Immunol; 1983 May; 52(2):350-4. PubMed ID: 6602677
[TBL] [Abstract][Full Text] [Related]
37. Serum IgE levels in patients with inflammatory bowel disease.
Levo Y; Shalit M; Wollner S; Fich A
Ann Allergy; 1986 Jan; 56(1):85-7. PubMed ID: 3946842
[TBL] [Abstract][Full Text] [Related]
38. Leukocyte migration inhibitory factor (LMIF) release by human colonic lymphocytes.
Bartnik W; ReMine SG; Shorter RG
Arch Immunol Ther Exp (Warsz); 1981; 29(3):397-405. PubMed ID: 6271090
[TBL] [Abstract][Full Text] [Related]
39. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
Schmitz-Moormann P; Himmelmann GW; Brandes JW
Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
[TBL] [Abstract][Full Text] [Related]
40. Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease.
Noguchi M; Hiwatashi N; Liu Z; Toyota T
J Gastroenterol; 1995 Nov; 30 Suppl 8():52-5. PubMed ID: 8563891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]